⌘K

Login Start Free

Home/Filings/4/0000899243-21-015839

4//SEC Filing

Reed Joshua 4

Accession 0000899243-21-015839

CIK 0001341235other

View on SEC.gov Company Profile

Filed

Apr 13, 8:00 PM ET

Accepted

Apr 14, 7:25 PM ET

Size

5.6 KB

Accession

0000899243-21-015839

Insider Transaction Report

Form 4

Period: 2021-04-12

Aldeyra Therapeutics, Inc.ALDX

Chief Financial Officer

Transactions

Award
Employee Stock Option (Right to Buy)
2021-04-12+150,185→ 150,185 total
Exercise: $11.71Exp: 2031-04-11→ Common Stock (150,185 underlying)

Footnotes (1)

[F1]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2021.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Aldeyra Therapeutics, Inc.

CIK 0001341235

Entity typeother

Related Parties

1

filerCIK 0001746541

Filing Metadata

Form type: 4
Filed: Apr 13, 8:00 PM ET
Accepted: Apr 14, 7:25 PM ET
Size: 5.6 KB

View on SEC.gov